Corvus Pharmaceuticals Inc. (CRVS) Declined -10.44% or -0.43 To Price $3.69 On Tuesday


Corvus Pharmaceuticals Inc. (CRVS) declined -10.44% or -0.43 to $3.69. It is about 86363 shares traded, which is 64.13% compare to the average total volume 134676. The market cap of CRVS is $108.05 million. The year to date change is -13.95%. The 52 week price range is from $3.22 to $13.91. Price of CRVS have changed -1.44% during last week. It have changed -18.25% over last month, -52.26% over last 3 months, -59.96% over last 6 months and -58.76% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CRVS is 5.56. It is 50.68% above current price. The 200-day Moving Averages for CRVS is 9.04. It is 144.99% above current price. The 52-week High is 13.91. It is 276.96% from the current price. The 52-week Low is 3.22. It is -12.74% from current price.

There are some statistics of CRVS. It is has market cap $108.05 million. The share outstanding is 29.28 million. The average volume is 134676. The percent of top 15 Institution holding is 105.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CRVS is -45.50%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CRVS is -41.69%.


Tags:

Share this post